Cargando…

Calpain-mediated cleavage of DARPP-32 in Alzheimer’s disease

Toxicity induced by aberrant protein aggregates in Alzheimer’s disease (AD) causes synaptic disconnection and concomitant progressive neurodegeneration that eventually impair cognitive function. cAMP-response element-binding protein (CREB) is a transcription factor involved in the molecular switch t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Kwangmin, Cho, Mi-Hyang, Seo, Jung-Han, Peak, Jongjin, Kong, Kyoung-Hye, Yoon, Seung-Yong, Kim, Dong-Hou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568975/
https://www.ncbi.nlm.nih.gov/pubmed/26178297
http://dx.doi.org/10.1111/acel.12374
_version_ 1782389980109209600
author Cho, Kwangmin
Cho, Mi-Hyang
Seo, Jung-Han
Peak, Jongjin
Kong, Kyoung-Hye
Yoon, Seung-Yong
Kim, Dong-Hou
author_facet Cho, Kwangmin
Cho, Mi-Hyang
Seo, Jung-Han
Peak, Jongjin
Kong, Kyoung-Hye
Yoon, Seung-Yong
Kim, Dong-Hou
author_sort Cho, Kwangmin
collection PubMed
description Toxicity induced by aberrant protein aggregates in Alzheimer’s disease (AD) causes synaptic disconnection and concomitant progressive neurodegeneration that eventually impair cognitive function. cAMP-response element-binding protein (CREB) is a transcription factor involved in the molecular switch that converts short-term to long-term memory. Although disturbances in CREB function have been suggested to cause memory deficits in both AD and AD animal models, the mechanism of CREB dysfunction is still unclear. Here, we show that the dopamine- and cAMP-regulated phosphoprotein 32 kDa (DARPP-32), a key inhibitor of protein phosphate-1 (PP-1) that regulates CREB phosphorylation, is cleaved by activated calpain in both AD brains and neuronal cells treated with amyloid-β or okadaic acid, a protein phosphatase-2A inhibitor that induces tau hyperphosphorylation and neuronal death. We found that DARPP-32 is mainly cleaved at Thr(153) by calpain and that this cleavage of DARPP-32 reduces CREB phosphorylation via loss of its inhibitory function on PP1. Our results suggest a novel mechanism of DARPP-32–CREB signalling dysregulation in AD.
format Online
Article
Text
id pubmed-4568975
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45689752015-10-01 Calpain-mediated cleavage of DARPP-32 in Alzheimer’s disease Cho, Kwangmin Cho, Mi-Hyang Seo, Jung-Han Peak, Jongjin Kong, Kyoung-Hye Yoon, Seung-Yong Kim, Dong-Hou Aging Cell Original Articles Toxicity induced by aberrant protein aggregates in Alzheimer’s disease (AD) causes synaptic disconnection and concomitant progressive neurodegeneration that eventually impair cognitive function. cAMP-response element-binding protein (CREB) is a transcription factor involved in the molecular switch that converts short-term to long-term memory. Although disturbances in CREB function have been suggested to cause memory deficits in both AD and AD animal models, the mechanism of CREB dysfunction is still unclear. Here, we show that the dopamine- and cAMP-regulated phosphoprotein 32 kDa (DARPP-32), a key inhibitor of protein phosphate-1 (PP-1) that regulates CREB phosphorylation, is cleaved by activated calpain in both AD brains and neuronal cells treated with amyloid-β or okadaic acid, a protein phosphatase-2A inhibitor that induces tau hyperphosphorylation and neuronal death. We found that DARPP-32 is mainly cleaved at Thr(153) by calpain and that this cleavage of DARPP-32 reduces CREB phosphorylation via loss of its inhibitory function on PP1. Our results suggest a novel mechanism of DARPP-32–CREB signalling dysregulation in AD. John Wiley & Sons, Ltd 2015-10 2015-07-14 /pmc/articles/PMC4568975/ /pubmed/26178297 http://dx.doi.org/10.1111/acel.12374 Text en © 2015 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Cho, Kwangmin
Cho, Mi-Hyang
Seo, Jung-Han
Peak, Jongjin
Kong, Kyoung-Hye
Yoon, Seung-Yong
Kim, Dong-Hou
Calpain-mediated cleavage of DARPP-32 in Alzheimer’s disease
title Calpain-mediated cleavage of DARPP-32 in Alzheimer’s disease
title_full Calpain-mediated cleavage of DARPP-32 in Alzheimer’s disease
title_fullStr Calpain-mediated cleavage of DARPP-32 in Alzheimer’s disease
title_full_unstemmed Calpain-mediated cleavage of DARPP-32 in Alzheimer’s disease
title_short Calpain-mediated cleavage of DARPP-32 in Alzheimer’s disease
title_sort calpain-mediated cleavage of darpp-32 in alzheimer’s disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568975/
https://www.ncbi.nlm.nih.gov/pubmed/26178297
http://dx.doi.org/10.1111/acel.12374
work_keys_str_mv AT chokwangmin calpainmediatedcleavageofdarpp32inalzheimersdisease
AT chomihyang calpainmediatedcleavageofdarpp32inalzheimersdisease
AT seojunghan calpainmediatedcleavageofdarpp32inalzheimersdisease
AT peakjongjin calpainmediatedcleavageofdarpp32inalzheimersdisease
AT kongkyounghye calpainmediatedcleavageofdarpp32inalzheimersdisease
AT yoonseungyong calpainmediatedcleavageofdarpp32inalzheimersdisease
AT kimdonghou calpainmediatedcleavageofdarpp32inalzheimersdisease